Citius Oncology (CTOR) Debt Ratio (2021)
Citius Oncology (CTOR) Debt Ratio (2021) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | -0.13 |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 0.42 |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | 0.60 |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | 0.32 |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 0.38 |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 0.29 |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 0.12 |
| 10 | Citius Oncology | 76.60 Mn | 76.60 Mn | 1.00 Mn | 0.03 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 1.03 |